Update on acute uncomplicated urinary tract infection in women

Postgraduate Medicine

Volumn 119, Issue 1, 2006, Pages

  Czaja, Christopher A ^a   Hooton, Thomas M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; ESTROGEN; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; NITROFURANTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPERMICIDAL AGENT; SULTAMICILLIN; URINARY TRACT ANTIINFECTIVE AGENT;

ACUTE DISEASE; ACUTE PYELONEPHRITIS; ANAMNESIS; BACTERIAL INFECTION; CLINICAL TRIAL; CRANBERRY JUICE; CYSTITIS; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DRUG HALF LIFE; ESCHERICHIA COLI; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; MICROBIOLOGICAL EXAMINATION; ONSET AGE; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; REVIEW; SELF EVALUATION; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; UNITED STATES; UNSPECIFIED SIDE EFFECT; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; URINE INCONTINENCE; AGE; DIFFERENTIAL DIAGNOSIS; FEMALE; RISK FACTOR;

ACUTE DISEASE; AGE FACTORS; ANTI-INFECTIVE AGENTS, URINARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; RISK FACTORS; UNITED STATES; URINARY TRACT INFECTIONS;

EID: 33746529236     PISSN: 00325481     EISSN: 12182583     Source Type: Journal    
DOI: 10.3810/pgm.2006.06.1639     Document Type: Review

References (23)

1. Foxman B, Barlow R, D'Arcy H, et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10( 8): 509-15
2. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. New Engl J Med 1996; 335 ( 7): 468-74
3. Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000; 182( 4): 1177-82
4. Jackson SL, Boyko EJ, Scholes D, et al. Predictors of urinary tract infection after menopause: a prospective study. Am J Med 2004; 117( 12): 903-11
5. Hu KK, Boyko EJ, Scholes D, et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 2004; 164( 9): 989-93
6. Ki M, Park T, Choi B, et al. The epidemiology of acute pyelonephritis in South Korea, 1997-1999. Am J Epidemiol 2004; 160( 10): 985-93
7. Scholes D, Hooton TM, Roberts PL, et al. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005; 142( 1): 20-7
8. Gupta K, Sahm DF, Mayfield D, et al. Antimicrobial resistance among uropathogens that cause communityacquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001; 33( 1): 89-94
9. Johnson JR. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am 2003; 17( 2): 261-78, viii
10. Gupta K, Stapleton AE, Hooton TM, et al. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis 1998; 78( 2): 446-50
11. Anderson GG, Palermo JJ, Schilling JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003; 301( 5629): 105-7
12. Bent S, Nallamothu BK, Simel DL, et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002; 287( 20): 2701-10
13. Saint S, Scholes D, Fihn SD, et al. The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women. Am J Med 1999; 106( 6): 636-41.
14. Gupta K, Hooton TM, Roberts PL, et al. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 2001; 135 ( 1): 9-16
15. Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004; 38 ( 8): 1150-58
16. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29( 4): 745-58
17. Raz R, Chazan B, Kennes Y, et al; Israeli Urinary Tract Infection Group. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002; 34( 9): 1165-9
18. Brown P, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uro-pathogenic Escherichi coli isolates in Michigan. Clin Infect Dis 2002; 34( 8): 1061-6
19. Hooton TM, Scholes D, Gupta K, et al. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005; 293(8): 949-55
20. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000; 283(12): 1583-90
21. Kontiokari T, Sundqvist K, Nuutinen M, et al. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001; 322( 7302): 1571
22. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329( 11): 753-6
23. Stapleton A. Novel approaches to prevention of urinary tract infections. Infect Dis Clin North Am 2003; 17( 2): 457-71